{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T09:41:23Z","timestamp":1785058883315,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1007\/bf03343886","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T18:15:09Z","timestamp":1397153709000},"page":"522-528","source":"Crossref","is-referenced-by-count":16,"title":["In vivo and in vitro expression of somatostatin receptors in two human thymomas with similar clinical presentation and different histological features"],"prefix":"10.1007","volume":"24","author":[{"given":"Diego","family":"Ferone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Kwekkeboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pivonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. D. J. J.","family":"Bogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. W. J.","family":"Lamberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"van Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. J.","family":"Hofland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,11]]},"reference":[{"key":"BF03343886_CR1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/edrv-12-4-450","volume":"12","author":"SWJ Lamberts","year":"1991","unstructured":"Lamberts S.W.J., Krenning E.P., Reubi J.C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr. Rev. 1991, 12: 450\u2013482.","journal-title":"Endocr. Rev."},{"key":"BF03343886_CR2","first-page":"1704","volume":"41","author":"DJ Kwekkeboom","year":"2000","unstructured":"Kwekkeboom D.J., Krenning E.P., de Jong M. Peptide receptor imaging and therapy. J. Nucl. Med. 2000, 41: 1704\u20131713.","journal-title":"J. Nucl. Med."},{"key":"BF03343886_CR3","first-page":"2356","volume":"81","author":"A Colao","year":"1996","unstructured":"Colao A., Ferone D., Lastoria S., Marzullo P., Cerbone G., Di Sarno A., Longobardi S., Merola B., Salvatore M., Lombardi G. Prediction of efficacy of octreotide therapy in patients with acromegaly. J. Clin. Endocrinol. Metab. 1996, 81: 2356\u20132362.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343886_CR4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2362.1994.tb00972.x","volume":"24","author":"PM Hagen van","year":"1994","unstructured":"van Hagen P.M., Krenning E.P., Kwekkeboom D.J., Reubi J.C., Anker-Lugtenburg P.J., L\u00f6wenberg B., Lamberts S.W.J. Somatostatin and the immune and haematopoietic system; a review. Eur. J. Clin. Invest. 1994, 24: 91\u201399.","journal-title":"Eur. J. Clin. Invest."},{"key":"BF03343886_CR5","unstructured":"Ferone D., van Hagen P.M., Colao A., Lombardi G., Lamberts S.W.J., Hofland L.J. Distribution, role and function of somatostatin receptors in immune cells. In: Lamberts S.W.J. (Ed.), Octreotide: The next decade. BioScientifica Ltd, Bristol, 1999, p. 259."},{"key":"BF03343886_CR6","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1182\/blood.V82.7.2143.2143","volume":"82","author":"JC Reubi","year":"1993","unstructured":"Reubi J.C., Waser B., Horisberger U., Krenning E., Lamberts S.W.J., Gebbers J.-O., Gersbach P., Laissue J.A. In vitro and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue. Blood 1993, 82: 2143\u20132151.","journal-title":"Blood"},{"key":"BF03343886_CR7","first-page":"634","volume":"39","author":"S Lastoria","year":"1998","unstructured":"Lastoria S., Vergara E., Palmieri G., Acampa W., Varrella P., Carac\u00f2 C., Bianco A.R., Muto P., Salvatore M. In vivo detection of malignant thymic masses by [111In-DTPA-D-Phe1]-octreotide scintigraphy. J. Nucl. Med. 1998, 39: 634\u2013639.","journal-title":"J. Nucl. Med."},{"key":"BF03343886_CR8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00003072-199901000-00006","volume":"24","author":"K Lin","year":"1999","unstructured":"Lin K., Nguyen R.D., Ettinger D.S., Chin B.B. Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma. Clin. Nucl. Med. 1999, 24: 24\u201328.","journal-title":"Clin. Nucl. Med."},{"key":"BF03343886_CR9","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1210\/jcem.85.4.6547","volume":"85","author":"D Ferone","year":"2000","unstructured":"Ferone D., van Hagen P.M., Kwekkeboom D.J., van Koetsveld P.M., Mooy D.M., Lichtenauer-Kaligis E.G.R., Sch\u00f6nbrunn A., Colao A., Lamberts S.W.J., Hofland L.J. Somatostatin receptors in human thymoma and inhibition of cell proliferation by octreotide in vitro. J. Clin. Endocrinol. Metab. 2000, 85: 1719\u20131726.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343886_CR10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM199701233360405","volume":"336","author":"G Palmieri","year":"1997","unstructured":"Palmieri G., Lastoria S., Colao A., Vergara E., Varrella P., Biondi E., Selleri C., Catalano L., Lombardi G., Bianco A.R., Salvatore M. Successful treatment of a patient with thymoma and pure red-cell aplasia with octreotide and prednisone. N. Engl. J. Med. 1997, 336: 263\u2013265.","journal-title":"N. Engl. J. Med."},{"key":"BF03343886_CR11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/endo.140.1.6398","volume":"140","author":"D Ferone","year":"1999","unstructured":"Ferone D., van Hagen P.M., van Koetsveld P.M., Zuijderwijk J., Mooy D., Lichtenauer-Kaligis E.G.R., Colao A., Bogers A.D.J.J., Lombardi G., Lamberts S.W.J., Hofland L.J. In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells. Endocrinology 1999, 140: 373\u2013380.","journal-title":"Endocrinology"},{"issue":"Suppl.2","key":"BF03343886_CR12","first-page":"5","volume":"31","author":"HK M\u00fcller-Hermelink","year":"1999","unstructured":"M\u00fcller-Hermelink H.K., Marx A. Pathological aspects of malignant and benign thymic disorders. Ann. Med. 1999, 31 (Suppl. 2): 5\u201314.","journal-title":"Ann. Med."},{"key":"BF03343886_CR13","first-page":"2002","volume":"37","author":"P Andersson","year":"1996","unstructured":"Andersson P., Forssell-Aronsson E., Johanson V., Wangberg B., Nilsson O., Fjalling M., Ahlman H. Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide. J. Nucl. Med. 1996, 37: 2002\u20132006.","journal-title":"J. Nucl. Med."},{"key":"BF03343886_CR14","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1210\/endo.136.9.7649075","volume":"136","author":"LJ Hofland","year":"1995","unstructured":"Hofland L.J., van Koetsveld P.M., Waaijers M., Zuyderwijk J., Breeman W.A., Lamberts S.W. Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide. Endocrinology 1995, 136: 3698\u20133706.","journal-title":"Endocrinology"},{"key":"BF03343886_CR15","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1210\/endo.137.9.8756582","volume":"137","author":"N Hukovic","year":"1996","unstructured":"Hukovic N., Panetta R., Kumar U., Patel Y.C. Agonist-dependent regulation of cloned human somatostatin receptor types 1-5 (hSSTR1-5): subtype selective internalization or upregulation. Endocrinology 1996, 137: 4046\u20134049.","journal-title":"Endocrinology"},{"key":"BF03343886_CR16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-1-4615-6355-6_17","volume-title":"Endocrine neoplasms","author":"LJ Hofland","year":"1997","unstructured":"Hofland L.J., Lamberts S.W.J. Somatostatin and somatostatin receptors. Diagnostic and therapueutic applications. In: Arnold A. (Ed.), Endocrine neoplasms. Kluwer Academic Publisher, Nowell, 1997, p. 365."},{"key":"BF03343886_CR17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s002689900452","volume":"22","author":"L Kolby","year":"1998","unstructured":"Kolby L., W\u00e4ngberg B., Ahlman H., Tisell L.-E., Fj\u00e4lling M., Forssell-Aronsson E., Nilsson O. Somatostatin receptor subtypes, octreotide scintigraphy, and clinical response to octreotide treatment in patients with neuroendocrine tumors. World J. Surg. 1998, 22: 679\u2013683.","journal-title":"World J. Surg."},{"key":"BF03343886_CR18","first-page":"1857","volume":"82","author":"KB Ain","year":"1997","unstructured":"Ain K.B., Kimberly D.T., Tofiq S., Venkartarman G. Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines. J. Clin. Endocrinol. Metab. 1997, 82: 1857\u20131862.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343886_CR19","first-page":"1413","volume":"76","author":"DJ Kwekkeboom","year":"1993","unstructured":"Kwekkeboom D.J., Reubi J.C., Lamberts S.W., Bruining H.A., Mulder A.H., Oei H.Y., Krenning E.P In vivo somatostatin receptor imaging in medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 1993, 76: 1413\u20131417.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343886_CR20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0046-8177(98)90112-5","volume":"29","author":"T Hishima","year":"1998","unstructured":"Hishima T., Fukayama M., Hayashi Y., Fujii T., Arai K., Shiozawa Y., Funata N., Koike M. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma. Hum. Pathol. 1998, 29: 330\u2013338.","journal-title":"Hum. Pathol."},{"key":"BF03343886_CR21","first-page":"1850","volume":"58","author":"I Virgolini","year":"1998","unstructured":"Virgolini I., Leimer M., Handmarker H., Lastoria S., Nischof C., Muto P., Pangerl T., Gludovacz D., Peck-Radosavljevic M., Lister-James J., Hamilton G., Kaserer K., Valent P., Dean R. Somatostatin receptor subtype specificity and in vivo binding of a novel turmor tracer, 99mTc-P829. Cancer Res. 1998, 58: 1850\u20131859.","journal-title":"Cancer Res."},{"key":"BF03343886_CR22","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1210\/endo.140.11.7126","volume":"140","author":"PM Smith-Jones","year":"1999","unstructured":"Smith-Jones P.M., Bischof C., Leimer M., Gludovacz D., Angelberger P., Pangerl T., Peck-Radosavljevic M., Hamilton G., Kaserer K., Kofler A., Valent P., Schlagbauer-Wadl H., Traub T., Virgolini I. DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy. Endocrinology 1999, 140: 5136\u20135148.","journal-title":"Endocrinology"},{"key":"BF03343886_CR23","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/annonc\/10.suppl_2.S23","volume":"10","author":"EP Krenning","year":"1999","unstructured":"Krenning E.P., de Jong M., Kooij P.P., Breeman W.A., Bakker W.H., de Herder W.W., van Eijck C.H., Kwekkeboom D.J., Jamar F., Pauwels S., Valkema R. Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy. Ann. Oncol. 1999, 10: S23\u2013S29.","journal-title":"Ann. Oncol."},{"key":"BF03343886_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.0.1410001","volume":"141","author":"AV Schally","year":"1999","unstructured":"Schally A.V., Nagy A. Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors. Eur. J. Endocrinol. 1999, 141: 1\u201314.","journal-title":"Eur. J. Endocrinol."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03343886.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03343886\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03343886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T15:58:30Z","timestamp":1597679910000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03343886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["BF03343886"],"URL":"https:\/\/doi.org\/10.1007\/bf03343886","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}